BIONOVO, INC.
$1.51 (-0.01)
NASDAQ: BNVID
Press Releases
Receive E-mail Alerts
09/02/10 - 8:00 am
Bionovo Receives NIH Grant to Develop Drugs for the Treatment of Female-Specific Obesity and Metabolic Syndrome
08/30/10 - 7:25 pm
Bionovo Receives Positive Guidance from FDA on Menerba®
08/30/10 - 6:00 pm
Bionovo Announces Reverse Stock Split
08/12/10 - 8:00 am
Bionovo to Present at the Southern California Investor Conference
08/11/10 - 8:00 am
Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board
08/10/10 - 8:00 am
LifeTech Capital Initiates Coverage of Bionovo
08/04/10 - 4:01 pm
Bionovo Announces Second Quarter 2010 Highlights and Financial Results
08/02/10 - 8:00 am
Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation
07/29/10 - 5:00 am
Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
07/28/10 - 9:00 am
Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
07/06/10 - 7:00 pm
Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
06/11/10 - 7:00 am
Bionovo Announces Publication Describing the Discovery of Distinct Classes of Genes Regulated By Estrogen Receptor Beta
05/27/10 - 7:01 am
Dr. Richard Weiner, Ph.D., Joins Bionovo Scientific Advisory Board
05/25/10 - 7:02 am
Bionovo Develops a High Throughput LC-MS/MS Tandem Quantification of Multiple Bioactive Compounds
05/11/10 - 4:04 pm
Bionovo Announces First Quarter 2010 Highlights and Financial Results
05/04/10 - 4:03 pm
Bionovo, Inc. to Announce First Quarter Fiscal Year 2010 Financial Results on Tuesday, May 11, 2010
04/28/10 - 3:31 pm
Bionovo to Hold Annual Shareholder Meeting May 3, 2010
04/20/10 - 6:45 pm
Bionovo Announces Patent Issuance for Bezielle(R) (BZL101) for Metastatic Breast Cancer
03/18/10 - 11:14 pm
Bionovo Notified by NASDAQ of Extension
03/15/10 - 4:04 pm
Bionovo Announces 2009 Highlights and Year-End Financial Results
03/08/10 - 4:04 pm
Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
02/10/10 - 8:05 am
Dr. Paul Pui-Hay But, Ph.D. Joins Bionovo, Inc. Scientific Advisory Board
01/14/10 - 8:06 am
Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
01/06/10 - 8:08 am
Dr. Marco Gambacciani, M.D. Joins Bionovo, Inc. Medical Advisory Board
12/29/09 - 8:03 am
Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer
11/05/09 - 4:04 pm
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
11/05/09 - 8:07 am
Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board
10/29/09 - 8:05 am
Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
10/20/09 - 8:06 am
Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
10/14/09 - 6:01 am
Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board
10/02/09 - 9:26 am
Bionovo Announces Pricing of Securities Offering
10/01/09 - 11:18 am
Bionovo Announces Publication Describing the Selective Anti-tumor Activity of its Drug Candidate BN108
09/25/09 - 8:02 am
Bionovo to Present at the Maxim Group Growth Conference
09/24/09 - 12:09 pm
Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
09/21/09 - 4:06 pm
Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency
09/03/09 - 8:04 am
Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
08/10/09 - 3:01 pm
Bionovo Announces Second Quarter 2009 Highlights and Financial Results
08/04/09 - 7:32 am
Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
08/03/09 - 4:17 pm
Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009
07/29/09 - 9:04 am
Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
07/17/09 - 8:02 am
Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
06/11/09 - 4:31 pm
Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
06/02/09 - 8:06 am
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
05/07/09 - 4:08 pm
Bionovo Announces First Quarter 2009 Highlights and Financial Results
04/30/09 - 9:03 am
Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
04/20/09 - 9:05 am
Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108
04/03/09 - 7:22 pm
Bionovo to Present at the Cambria Capital Investor Meeting
03/18/09 - 5:01 pm
Bionovo to Present at Wall Street Analyst Forum's 20th Annual Institutional Investor Conference
03/12/09 - 4:16 pm
Bionovo Announces 2008 Highlights and Year-End Financial Results
03/06/09 - 1:20 pm
Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
03/02/09 - 8:05 am
Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
02/17/09 - 8:07 am
Bert W. O'Malley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovo's Scientific Advisory Board
02/09/09 - 8:06 am
Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovo's Scientific Advisory Board
02/04/09 - 1:06 pm
Bionovo Announces Presentation at the National Cancer Institute
01/15/09 - 8:03 am
Bionovo Announces Cost Control Measures Taken
01/02/09 - 6:04 pm
Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
12/15/08 - 3:02 pm
Willa A. Hsueh, M.D., Joins Bionovo's Scientific Advisory Board
12/12/08 - 8:03 am
Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
12/12/08 - 8:02 am
Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
12/03/08 - 7:02 am
Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
12/02/08 - 10:40 am
Bionovo to Present at the Piper Jaffray Healthcare Conference
11/20/08 - 1:34 pm
Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11/12/08 - 8:06 am
Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board
11/11/08 - 8:07 am
Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
11/03/08 - 4:42 pm
Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
11/03/08 - 4:40 pm
Bionovo Reports Third Quarter 2008 Financial Results
